As of September 2026 Immix Biopharma has a market cap of S$1.27 Billion. This makes Immix Biopharma the world's 6384th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Aug 31st, 2026 the market cap of Immix Biopharma was reported to be: